{{Rsnum
|rsid=61469810
|Gene=CYP3A43
|Chromosome=7
|position=99836455
|Orientation=plus
|GMAF=0.09596
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(-;-)
|geno2=(-;A)
|geno3=(A;A)
|Gene_s=CYP3A43
}}{{PharmGKB
|RSID=rs61469810
|Name_s=CYP3A43: 177 delA; *2A; Y25L
|Gene_s=CYP3A, CYP3A43
|Feature=Intron, Exon/NonSyn
|Evidence=PubMed ID:14695544
|Annotation=The CYP3A43*2A allele is characterized by the 177 A deletion variant in exon 2. This variant cauces a frameshift leading to a premature stopcodon at position 64.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162356065
}}{{GET Evidence
|gene=CYP3A43
|aa_change=Tyr25Shift
|aa_change_short=Y25Shift
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs61469810
|overall_frequency_n=19
|overall_frequency_d=128
|overall_frequency=0.148438
|n_genomes=13
|n_genomes_annotated=0
|n_haplomes=13
|n_articles=0
|n_articles_annotated=0
|nblosum100=4
|autoscore=1
|webscore=N
}}